Related references
Note: Only part of the references are listed.Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1
Melissa Cudmore et al.
CIRCULATION (2007)
Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension
J. Wipff et al.
RHEUMATOLOGY (2007)
New therapeutic strategies in the management of systemic sclerosis
Yannick Allanore et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Angiogenesis and vasculogenesis in systemic sclerosis
J. H. W. Distler et al.
RHEUMATOLOGY (2006)
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
Richard J. Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Transforming growth factor-βs and vascular disorders
Alex Bobik
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine
A. Dooley et al.
RHEUMATOLOGY (2006)
Mechanisms and consequences of fibrosis in systemic sclerosis
CP Denton et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Soluble endoglin contributes to the pathogenesis of preeclampsia
Shivalingappa Venkatesha et al.
NATURE MEDICINE (2006)
A clue for telangiectasis in systemic sclerosis: Elevated serum soluble endoglin levels in patients with the limited cutaneous form of the disease
M. Fujimoto et al.
DERMATOLOGY (2006)
Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis
O Distler et al.
CIRCULATION RESEARCH (2004)
Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1
Y Allanore et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Cardiovascular biology of the asymmetric dimethylarginine: Dimethylarginine dimethylaminohydrolase pathway
P Vallance et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
D Mukerjee et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers
O Distler et al.
ARTHRITIS RESEARCH (2002)
Share Paper
